1. Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

2. Lipid/Lipoprotein Profile After a 6-Week Treatment with Ezetimibe (10 mg/d) and Simvastatin (40 mg/d), Simvastatin (40 mg/d) alone, Ezetimibe (10 mg/d) alone and Placebo
Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

3. Kinetic parameters of ApoB-100 in VLDL, IDL, and LDL and ApoB-48 in TRL following the Placebo, Ezetimibe (10 mg) alone, Simvastatin (40 mg) alone and Ezetimibe (10 mg) plus Simvastatin (40 mg) treatment phases
Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

4. Effect of 10 mg/d of ezetimibe, 40 mg/d of simvastatin and 10 mg/d of ezetimibe plus 40 mg/d of simvastatin on markers of cholesterol synthesis and intestinal absorption
Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

5. Correlation between percentage changes in TRL apoB-48 pool size and percentage changes in TRL apoB-48 production rate following combination therapy with ezetimibe (10 mg/day) and simvastatin (40 mg/day) versus placebo
Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

6. Correlation between percentage changes in LDL apoB-100 pool size and percentage changes in LDL apoB-100 fractional catabolic rate following combination therapy with ezetimibe (10 mg/day) and simvastatin (40 mg/day) versus placebo
Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]